雷帕鸣如何购买

, formerly known as rapamycin, is a lipophilic triene nitrogen-containing macrolide antibiotic compound produced by Streptomyces hygroscopieus isolated from soil samples of Easier Island in the Pacific by Vezina and others at the Ayerst Laboratory in Canada in 1975.

Since Rapamin is already on the market in China, patients can purchase the drug with the prescription. However, the price of the original drug is a bit expensive, and many patients cannot accept it. The medicines produced by Biocon in India are slightly cheaper, about $200. Patients can go abroad to purchase medicines in person, or they can choose domestic regular overseas medical service companies, such as Medical Companion Travel. We will provide you with drug purchasing channels to ensure that the drugs you purchase are from legitimate sources.

The editor does not recommend that you shop online or choose personal shopping as these two methods are not very safe. There is no guarantee of the source of medicines, and it is easy to purchase ineffective medicines, which will delay your subsequent treatment.

Rapamin should be taken orally once a day. Concomitant use with cyclosporine and corticosteroids is recommended. Start taking your medications as soon as possible after your transplant. In new transplant recipients, the initial loading should be three times the maintenance dose. The recommended loading dose for kidney transplant recipients is 6 mg and the maintenance dose is 2 mg/day.

Rapamin was initially used as a low-toxic antifungal agent and immunosuppressant. In 1989, RAPA was tested as a new drug for organ transplant rejection. From animal experiments and depending on the impact of clinical application, it is an effective and good, low-toxic new immunosuppressant without nephrotoxicity. Compared with cyclosporine, rapamycin has a smaller oral dose (only 2 to 3 mg per serving), a stronger anti-rejection effect, and fewer side effects.

Therefore, since its listing as a listed company, Rapamin has rapidly developed into a commonly used oral immune system inhibitor for patients undergoing transplantation of different organs around the world (especially for kidney transplantation). Rapamin is a serine/threonine kinase regulated by phosphoinositide-3-kinase and an mTOR (mammalian target of rapamycin) inhibitor. mTOR is a protein involved in the control of many other cell culture processes, including artificial vasculogenesis and cell synthesis, making it a reasonable target for inhibiting tumors with severe angiogenesis. Recently, in reports on the clinical application of multiple technologies involving vascular malformations and refractory vascular tumors, rapamycin has been shown to have no significant effect in vascular and lymphoproliferative diseases.

Patients must use it in accordance with the doctor's instructions, and seek medical treatment in time if a serious drug reaction occurs.

Recommended related articles: Is Biocon Repamin included in medical insurance in India?